These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30420835)

  • 1. Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China.
    Liu G; Dou J; Pan Y; Yan Y; Zhu H; Lu J; Gaisano H; Ji L; He Y
    Front Endocrinol (Lausanne); 2018; 9():639. PubMed ID: 30420835
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real-world data.
    Peng Y; Xu P; Shi J; Zhang Y; Wang S; Zheng Q; Wang Y; Ke T; Li L; Zhao D; Dai Y; Dong Q; Ji B; Xu F; Gu W; Wang W
    J Diabetes; 2022 Feb; 14(2):134-143. PubMed ID: 35023626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Human Premixed and Basal Plus Short-Acting Insulin Regimens for Individuals With Type 2 Diabetes During Ramadan Fasting.
    Altemimi MT; Odhaib SA; Imran HJ; Alhamza A; Almomin A; Mansour AA
    Cureus; 2020 Dec; 12(12):e11976. PubMed ID: 33425548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009-2020.
    Hankosky ER; Schapiro D; Gunn KB; Lubelczyk EB; Mitroi J; Nelson DR
    Diabetes Ther; 2023 Jun; 14(6):967-975. PubMed ID: 37067668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin.
    Chen YH; Li HZ; Tang ZS; Xu L; Wang H; Feng B
    Diabetes Ther; 2019 Apr; 10(2):463-471. PubMed ID: 30659420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin.
    van Brunt K; Curtis B; Ivanyi T; Balogh E; Chalkiadaki C; MacLachlan S; Neasham D; Raluy-Callado M
    Diabetes Ther; 2016 Dec; 7(4):793-807. PubMed ID: 27796906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
    Lavernia F
    Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
    Rolla AR; Rakel RE
    Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data.
    Anyanwagu U; Mamza J; Gordon J; Donnelly R; Idris I
    Diabet Med; 2017 Dec; 34(12):1728-1736. PubMed ID: 28945928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis.
    Gao Y; Wang K; Chen Y; Shen L; Hou J; Xuan J; Liu B
    Diabetes Ther; 2018 Apr; 9(2):673-682. PubMed ID: 29476413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study).
    Brož J; Janíčková Žďárská D; Urbanová J; Piťhová P; Doničová V; Pálová S; Pelechová B; Smržová A; Kvapil M
    Diabetes Ther; 2021 Jul; 12(7):1799-1808. PubMed ID: 34028699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS).
    Ramachandran A; Jain SM; Mukherjee S; Phatak S; Pitale S; Singh SK; Agrawal N; Majumdar A; Deshpande N; Jhulka S; Minakshisundaram S; Chawla M; Lodha S; Maheshwari A; Makkar BM; Rao S; Shah P; Ghosh R; Mohanasundaram S; Menon S; Chodankar D; Kanade V; Trivedi C
    Ther Adv Endocrinol Metab; 2020; 11():2042018820937217. PubMed ID: 32647562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personality Traits Do Not Have Influence on Glycemic Control in Outpatients with Type 2 Diabetes Mellitus.
    Yasui-Furukori N; Murakami H; Otaka H; Tanabe J; Yanagimachi M; Murabayashi M; Matsumura K; Matsuhashi Y; Nakayama H; Mizushiri S; Sugawara N; Daimon M; Shimoda K
    Psychiatry Investig; 2020 Jan; 17(1):78-84. PubMed ID: 31995975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Remission Rate of Type 2 Diabetes Outpatients with Premixed Insulin: The Result of a 5-Year Prospective Study.
    Liu FP; Sun MH; Zhao JY; Yang M; Zhou XJ; Zhang ZW; Dong JJ; Liao L
    Horm Metab Res; 2020 May; 52(5):316-321. PubMed ID: 32403146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
    Chamarthi B; Cincotta AH
    Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based clinical use of insulin premixtures.
    Tambascia MA; Nery M; Gross JL; Ermetice MN; de Oliveira CP
    Diabetol Metab Syndr; 2013 Sep; 5(1):50. PubMed ID: 24011173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross-sectional survey of 15,652 patients.
    Arai K; Takai M; Hirao K; Matsuba I; Matoba K; Takeda H; Kanamori A; Yamauchi M; Mori H; Terauchi Y
    J Diabetes Investig; 2012 Aug; 3(4):396-401. PubMed ID: 24843596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial.
    Yang W; Yang Z; Zhao J; Lu H; Luo T
    Trials; 2016 Sep; 17(1):470. PubMed ID: 27669747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.